Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Learn more at www.sanofigenzyme.com . Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare.

Genzyme Corporation (a Sanofi company) and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

Sanofi believes that Health is a social asset: a basic right, a source of well-being and a driver of economic growth. Through dialogues and partnerships with civil society and decision makers, the Public Affairs team contributes to engage with key stakeholders that jointly define the best health care systems to benefit citizens and patients around the globe within an innovation-friendly business environment with high ethical standards.

Public Affairs (PA) is one of the key functions within the External Affairs Global group. PA drives the strategy setting, engagement, and activation of all external stakeholders who drive or shape the policies that determine Sanofi’s ability to successfully secure patient’s access to medicines. PA typically drives multi-stakeholder strategies and campaigns (i.e., coalition building) to ensure that health guidelines and recommendations support patients’ access to innovation. PA is organized by Therapeutic Areas (TA) and offers support to each Franchise across geographies.

Sanofi Genzyme in partnership with Regeneron are commercializing a human monoclonal antibody directed at a dual inhibitor of Type 2 cytokines IL4 and IL13, known as dupilumab, which induces differentiation, maturation and migration of several cells involved in atopic dermatitis and asthma pathogenesis. Dupilumab has been approved in various countries for the treatment of uncontrolled moderate-to-severe atopic dermatitis (AD) and is marketed as Dupixent. Dupilumab is really a pipeline in a product and is also in Phase III clinical trials in asthma, and in Phase II for nasal polyposis and eosinophilic esophagitis (EoE). Other indications are currently being evaluated. Dupilumab is launching in 20 countries in 2018.

Sanofi Genzyme’s Oncology franchise has a diverse and growing portfolio. This includes the late-stage candidates anti-CD38 (isatuximab) and PD1-inhibitor (Cemiplimab) in multiple myeloma as well as multiple early pipeline / Phase II assets in large tumor types, including breast, lung and GI tumors. Our marketed products span prostate, colorectal and hematological malignancies.

The Head Public Affairs- Immunology/Oncology EM will build, tailor and execute the specific Public Affairs strategies programs and initiatives in the key emerging markets, engaging the right external stakeholders to support the company’s goal of opening access to innovation for patients. He/she will also partner with the regional and local Public Affairs staff that supports the TA, Global and Regional TA and Franchise Heads and closely coordinate with the Head of Global Public Affairs- Dupilumab who is based in Paris.

More specifically, the person will work to:

Drive the adaptation and the implementation of public affairs strategies supporting the long-term (disease-driven) and the short-term (product-driven) business objectives for the priority Immunology and Oncology products in the Emerging Markets (EM)

Establish partnerships with critical external stakeholders to prepare the launch of Dupilumab and where relevant of the oncology products in the specific diseases areas and develop an internal understanding of their expectations.

Contribute to establish the reputation and unique positioning of the Sanofi in the oncology space

Ensure with regions and / or appropriate functions the Public Affairs excellence and readiness of the affiliates and support as needed

The role will report to the Global Head of Public Affairs Specialty Care who is overseeing public affairs support for the Multiple Sclerosis, Immunology and Oncology portfolio. The person will join the global Public Affairs team in Cambridge, MA- USA and will also be part of the Immunology/Oncology EM Leadership Team.

2- Job Duties and Responsibilities

Drive Public Affairs Blueprint implementation in the affiliates and support Stakeholder Engagement Plan in coordination with external affairs functions and medical affairs

Ability to drive projects and initiatives and execute successfully in a complex environment, working with multiple internal and external stakeholders. Proven track record successfully executing complex projects and initiatives, on time, within budget, with measurement of results

Must be able to demonstrate ability to be a good team player and engage with a wide variety of stakeholders from different functions/ Experience working as an individual contributor leading by example without direct line reports.

5. LEAD COMPETENCIES AND BEHAVIORS

Think Strategically

Demonstrates a deep understanding of trends and facts that impact our business.

Actively works to gain genuine understanding of the customers’ perspective.

Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

#LI-SA

#GD-SA

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Sanofi, Empowering Life

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.